Estimation of mechanism-of-action of pharmaceutical compounds based on quantitative systems pharmacology

  • Saito Ryuta
    Discovery Technology Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation

Bibliographic Information

Other Title
  • 創薬におけるQuantitative Systems Pharmacologyの活用:薬物作用メカニズムの解明に向けた研究
  • 創薬シリーズ(8)創薬研究の新潮流(28)創薬におけるQuantitative Systems Pharmacologyの活用 : 薬物作用メカニズムの解明に向けた研究
  • ソウヤク シリーズ(8)ソウヤク ケンキュウ ノ シン チョウリュウ(28)ソウヤク ニ オケル Quantitative Systems Pharmacology ノ カツヨウ : ヤクブツ サヨウ メカニズム ノ カイメイ ニ ムケタ ケンキュウ

Search this article

Description

<p>To accelerate drug discovery and development, improve R&D efficiency and facilitate scientific decision making, quantitative systems pharmacology (QSP) is increasingly being utilized in the pharmaceutical and biotech industry. QSP approach has emerged as a central technology in innovative framework based on “learn and confirm” cycle, which is currently called as model-informed drug discovery and development (MID3). QSP approach is supporting the rational decision in drug discovery and development from exploratory research to late-stage clinical development, and enables selection/validation of novel target molecules, identification of mechanism-of-action of pharmacological/toxicological compounds, prioritization of pharmaceutical candidates, facilitating translational research, optimization of clinical trials, and others. In this review paper, I explained summary and effectiveness of QSP approach by showing two our case-studies related to identification of mechanism-of-action of compounds. These are 1: differentiation of thrombin inhibitors and 2: endocrine disrupting compounds, they have been good practices in my experiences of applying QSP at pharmaceutical company.</p>

Journal

Citations (1)*help

See more

References(12)*help

See more

Details 詳細情報について

Report a problem

Back to top